Capricor Therapeutics (CAPR) Net Equity Issued and Repurchased (2009 - 2026)
Capricor Therapeutics (CAPR) reported Net Equity Issued and Repurchased of $2.1 million for Q2 2026, compared with $19,580 a year earlier and up 42.6% from the prior quarter.
Powered by 
Analysis
Capricor Therapeutics (CAPR) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Capricor Therapeutics' Net Equity Issued and Repurchased came in at $240.53 million, up 62.4% year-over-year; for FY2025, it came in at $237.03 million, up 55.6% from FY2024.
- Net Equity Issued and Repurchased has increased for three consecutive years, with a five-year compound annual growth rate of 54.0% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $152.32 million in FY2024 (+497.0%), $25.52 million in FY2023 (+431.2%), $4.8 million in FY2022 (-76.2%) and $20.17 million in FY2021 (-26.2%).
- Five-year quarterly Net Equity Issued and Repurchased spans a low of -$1,543 in Q4 2021 and a high of $236.96 million in Q4 2025.
- Year over year, Net Equity Issued and Repurchased gained in two of the last five quarters, with growth averaging 29.1%.
- The high point for year-over-year Net Equity Issued and Repurchased in five years was Q4 2023 (growth of 692.4%); the low point was Q3 2025 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.47 million (Q1 2026), $236.96 million (Q4 2025) and $6,950 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Capricor Therapeutics | 515.69 Mn | -516.56 Mn | - | 88,700.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 88,700.00 |
| Jun 30, 2026 | 2.10 Mn |
| Mar 31, 2026 | 1.47 Mn |
| Dec 31, 2025 | 248.82 Mn |
| Sep 30, 2025 | 6,950.00 |
| Jun 30, 2025 | 19,580.00 |
| Mar 31, 2025 | 50,354.00 |
| Dec 31, 2024 | 81.09 Mn |
| Sep 30, 2024 | 67.33 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Mar 31, 2024 | 2.29 Mn |
| Dec 31, 2023 | 23.17 Mn |
| Sep 30, 2023 | 221,081.00 |
| Jun 30, 2023 | 2.19 Mn |
| Mar 31, 2023 | 3,895.00 |
| Dec 31, 2022 | 2.95 Mn |
| Sep 30, 2022 | 1.88 Mn |
| Jun 30, 2022 | 15,006.00 |
| Mar 31, 2022 | 27,465.00 |
| Dec 31, 2021 | 42,370.00 |
API Access
Capricor Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CAPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CAPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CAPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();